Related Experiment Video
Updated: Sep 29, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[Newer pathophysiologic considerations and treatment of neonatal respiratory distress syndrome (RDS)]
1Department of Pediatrics, Iwate Medical University, Morioka.
Abstract:
RDS is the major cause of morbidity and mortality in preterm infants. Hochheim first noted the pathologic appearance of the lungs with RDS in 1903, which included alveolar collapse associated with dilatation of the alveolar ducts and terminal bronchioles. This important finding now can be best explained by the newer model of pulmonary micromechanics proposed by Weibel and Bachofen. In this model, alveoli are not individual structures, but subunits of the alveolar duct system. The alveolar stability requires particular properties of both the fibrous skeleton and the alveolar surfactant film. With increasing surface forces resulting from surfactant deficiency, the alveolar volumes and surface areas decrease, more septal segments are folded up between the adjacent ducts, thereby widening the duct system and terminal bronchioles. In this situation, the shear forces triggered by mechanical ventilation cause damage of the terminal airways with increased permeability of plasma proteins into the airspaces, which tends to aggravate alveolar instability further. Exogenous surfactant replacement produced excellent results which decreased the pulmonary complications of RDS significantly with no adverse effects. In the not too distant future this therapy will be regularly practiced in NICU.
Related Concept Videos
Breathing
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Rheumatic Heart Disease IV: Nursing Management
Respiratory Syncytial Virus Disease

